Narcolepsy Type 2 Clinical Trials in Cincinnati, Ohio
5 recruitingCincinnati, Ohio
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Narcolepsy Type 2
Alkermes, Inc.176 enrolled15 locationsNCT07502443
Recruiting
Phase 2
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Narcolepsy Type 2
Takeda88 enrolled52 locationsNCT06952699
Recruiting
Phase 2
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Idiopathic HypersomniaNarcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited248 enrolled37 locationsNCT06752668
Recruiting
Phase 2
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Idiopathic HypersomniaNarcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited90 enrolled24 locationsNCT07096674
Recruiting
Phase 2Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Idiopathic HypersomniaNarcolepsy Type 1Narcolepsy Type 2
Alkermes, Inc.256 enrolled46 locationsNCT06767683